Income Statement Reflect Scientific, Inc.
Stocks
RSCF
US75866F1012
Medical Equipment, Supplies & Distribution
|
Market Closed -
OTC Markets
15:43:39 2026-06-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.0475 USD | +0.21% |
|
+1.06% | -10.04% |
| 25-09-29 | Reflect Scientific secures over $1 million in follow-on orders for B-90 Blast Freezer | RE |
| 25-09-29 | Reflect Scientific Secures over $1 Million in Follow-On Orders for B-90 Blast Freezer | CI |
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.61M | 2.79M | 2.81M | 2.04M | 1.08M | |||||
Total Revenues | 1.61M | 2.79M | 2.81M | 2.04M | 1.08M | |||||
Cost of Goods Sold, Total | 618K | 1.07M | 884K | 822K | 484K | |||||
Gross Profit | 992K | 1.72M | 1.93M | 1.22M | 596K | |||||
Selling General & Admin Expenses, Total | 976K | 885K | 1.04M | 1.06M | 1.03M | |||||
R&D Expenses | 210K | 185K | 58.34K | 73.42K | 29.54K | |||||
Other Operating Expenses, Total | 1.19M | 1.07M | 1.1M | 1.13M | 1.06M | |||||
Operating Income | -195K | 651K | 828K | 90.1K | -467K | |||||
Interest Expense, Total | -755 | -890 | - | - | - | |||||
Interest And Investment Income | - | - | - | - | 8.56K | |||||
Net Interest Expenses | -755 | -890 | - | - | 8.56K | |||||
Other Non Operating Income (Expenses) | - | 10K | - | - | - | |||||
EBT, Excl. Unusual Items | -196K | 660K | 828K | 90.1K | -459K | |||||
Other Unusual Items | - | - | 111K | - | - | |||||
EBT, Incl. Unusual Items | -196K | 660K | 939K | 90.1K | -459K | |||||
Income Tax Expense | - | - | - | 702 | 312 | |||||
Earnings From Continuing Operations | -196K | 660K | 939K | 89.4K | -459K | |||||
Net Income to Company | -196K | 660K | 939K | 89.4K | -459K | |||||
Net Income - (IS) | -196K | 660K | 939K | 89.4K | -459K | |||||
Net Income to Common Incl Extra Items | -196K | 660K | 939K | 89.4K | -459K | |||||
Net Income to Common Excl. Extra Items | -196K | 660K | 939K | 89.4K | -459K | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0 | 0.01 | 0.01 | 0 | -0.01 | |||||
Basic EPS - Continuing Operations | -0 | 0.01 | 0.01 | 0 | -0.01 | |||||
Basic Weighted Average Shares Outstanding | 79.12M | 84.74M | 84.74M | 84.99M | 85.22M | |||||
Net EPS - Diluted | -0 | 0.01 | 0.01 | 0 | -0.01 | |||||
Diluted EPS - Continuing Operations | -0 | 0.01 | 0.01 | 0 | -0.01 | |||||
Diluted Weighted Average Shares Outstanding | 79.12M | 84.74M | 84.74M | 85.44M | 85.22M | |||||
Normalized Basic EPS | -0 | 0 | 0.01 | 0 | -0 | |||||
Normalized Diluted EPS | -0 | 0 | 0.01 | 0 | -0 | |||||
Supplemental Items | ||||||||||
EBITDA | -191K | 655K | 832K | - | - | |||||
EBITA | -195K | 651K | 828K | 90.1K | -467K | |||||
EBIT | -195K | 651K | 828K | 90.1K | -467K | |||||
EBITDAR | -142K | 703K | 899K | - | - | |||||
Effective Tax Rate - (Ratio) | - | - | - | 0.78 | -0.07 | |||||
Current Domestic Taxes | - | - | - | - | 312 | |||||
Total Current Taxes | - | - | - | - | 312 | |||||
Normalized Net Income | -122K | 413K | 517K | 56.31K | -287K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 53.39K | 22.18K | 21.97K | 77.31K | 45.83K | |||||
Selling and Marketing Expenses | - | - | - | - | - | |||||
General and Administrative Expenses | 408K | 350K | 436K | 420K | 389K | |||||
Research And Development Expense From Footnotes | 210K | 185K | 58.34K | 73.42K | 29.54K | |||||
Net Rental Expense, Total | 48.91K | 48.52K | 67.23K | 67.32K | 88.44K | |||||
Imputed Operating Lease Interest Expense | 7.62K | 1.99K | - | - | - | |||||
Imputed Operating Lease Depreciation | 41.28K | 46.53K | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | 200K | - | - | - | 55K | |||||
Stock-Based Comp., Other (Total) | 30.75K | - | 27.5K | 27.5K | - | |||||
Total Stock-Based Compensation | 231K | - | 27.5K | 27.5K | 55K |
- Stock Market
- Stocks
- RSCF Stock
- Financials Reflect Scientific, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















